Doctor profile · Federal record

Dr. Stacy Weible-Torres, ARNP

Family Nurse Practitioner (CMS: Nurse Practitioner) · Oklahoma City, OK

  • NPI 1891005823
  • Accepts Medicare
  • 17 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
13921 N Meridian Ave Ste 100
Oklahoma City, OK 731341106
(405) 752-9600
fax (405) 752-9650
Mailing address
4120 W Memorial RD Ste 218
Oklahoma City, OK 731209322

Credentials & registration

NPPES · NUCC
NPI registered
October 2010 — 16 yrs on file
Profile last updated
February 15, 2024
Year of graduation
2009 — 17 yrs since
Specialty taxonomy
363LF0000X — NUCC code
State license (1)
Oklahoma #R95222

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1891005823. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,685
Distinct HCPCS
10
Medicare allowed
$257,837
HCPCS Description Services Patients Avg allowed
99213 Established patient office or other outpatient visit, 20-29 minutes 1,829 253 $71
80307 Testing for presence of drug, by chemistry analyzers 433 187 $60
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 431 186 $111
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 288 177 $153
36415 Insertion of needle into vein for collection of blood sample 81 81 $8
84443 Blood test, thyroid stimulating hormone (tsh) 80 80 $17
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 80 80 $8
80053 Blood test, comprehensive group of blood chemicals 79 79 $10
82306 Vitamin d-3 level 79 79 $29
96138 Administration of psychological or neuropsychological test by technician, first 30 minutes 76 76 $25

In context: peer comparison

Among 116 peers in Oklahoma City Family Nurse Practitioner, average services per provider: 130. This provider delivers 28× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,280
Transactions
183
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 38 $552.75
Ucb, INC. 15 $363.57
Pfizer INC. 24 $308.93
Lundbeck LLC 18 $253.80
Teva Pharmaceuticals USA, INC. 18 $238.14
Sk Life Science, INC. 10 $203.99
Merz Pharmaceuticals, LLC 9 $196.61
Novartis Pharmaceuticals Corporation 13 $169.15
Neurocrine Biosciences, INC. 10 $149.23
Lilly USA, LLC 6 $100.35
Tg Therapeutics, INC. 5 $98.97
Genentech USA, INC. 5 $96.57
Eisai INC. 5 $90.97
Csl Behring 4 $79.85
Alexion Pharmaceuticals, INC. 3 $74.42

By nature of payment

Food and Beverage
$3,280

Frequently asked questions

Auto-generated from federal data
What is Dr. Stacy Weible-Torres's medical specialty?
Dr. Stacy Weible-Torres practices Family Nurse Practitioner in Oklahoma City, OK.
Where does Dr. Stacy Weible-Torres practice?
Dr. Stacy Weible-Torres practices at 13921 N Meridian Ave Ste 100, Oklahoma City, OK 731341106. Office phone: 4057529600.
What is Dr. Stacy Weible-Torres's NPI?
Dr. Stacy Weible-Torres's National Provider Identifier (NPI) is 1891005823, issued by NPPES.
Does Dr. Stacy Weible-Torres accept Medicare assignment?
Yes. Dr. Stacy Weible-Torres accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stacy Weible-Torres commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Testing for presence of drug, by chemistry analyzers (HCPCS 80307); Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS G0480). Source: CMS Medicare Physician & Other Practitioners file.